Healthcare & Life Sciences

FDA Idea Lab for Home Health Medical Devices

The FDA has launched an Idea Lab as part of its Home as a Health Care Hub initiative to foster the development of new home health medical devices. The lab focuses on diabetes management as a test case, aiming to integrate devices for prevention, diagnosis, treatment, rehabilitation, and monitoring into patients' lifestyles.

FDA Approves First Device for Pancreatic Cancer

The FDA has approved the first medical device specifically designed to treat pancreatic cancer. This approval marks a significant advancement in the treatment options available for patients diagnosed with this disease.

FDA Guidance: Cancer Trial Eligibility Criteria - Laboratory Values

The FDA has issued new guidance on cancer clinical trial eligibility criteria, specifically focusing on laboratory values. The guidance aims to help sponsors and institutional review boards select appropriate laboratory values to avoid unjustified exclusions of diverse patient populations.

FDA Guidance: Cancer Trial Eligibility Criteria

The FDA has issued new guidance regarding eligibility criteria for cancer clinical trials, specifically addressing washout periods and concomitant medications. This guidance aims to help sponsors and IRBs develop trials that are inclusive while ensuring participant safety. Comments on the guidance can be submitted at any time.

FDA Final Guidance on Bioresearch Monitoring Inspections

The FDA has issued final guidance detailing processes and practices for Bioresearch Monitoring inspections, as mandated by the Food and Drug Omnibus Reform Act of 2022. This guidance outlines record and information requirements, communication best practices, and inspection conduct for regulated entities.

FDA Guidance: Inclusive Cancer Trial Eligibility Criteria

The FDA has issued new guidance recommending that sponsors and institutional review boards expand eligibility criteria for cancer clinical trials to include a wider range of patients, particularly concerning performance status. This aims to improve the diversity of clinical trial populations and ensure broader applicability of cancer treatments.

Medline Industries Recalls Electrophysiology and Ultrasound Catheters

Medline Industries is expanding a recall of reprocessed electrophysiology and ultrasound catheters due to potential residual particulates. The FDA has classified this as the most serious type of recall, as the devices could cause serious injury or death. Affected customers are instructed to return or destroy the product.

FDA Identifies Infusion Pump Software Correction as Most Serious Recall

The FDA has identified a software correction for the Fresenius Kabi Ivenix Large Volume Pump as its most serious type of recall, indicating a potential risk of serious injury or death. Affected healthcare providers are urged to update the pump software to version 5.10.2 as soon as possible and implement temporary risk mitigation measures.

FDA Recall of Silintan Capsules for Undeclared Meloxicam

Anthony Trinh, 123Herbals LLC is voluntarily recalling all lots of Silintan capsules due to the presence of undeclared meloxicam, an approved NSAID. The FDA analysis found the product to be an unapproved new drug, posing risks of serious health events.

Green Lumber Recalls Dietary Supplements for Undeclared Tadalafil

Green Lumber Holding, LLC is updating a recall for counterfeit dietary supplements falsely marketed as Green Lumber. The counterfeit products contain undeclared Tadalafil, a prescription drug, posing potential health risks. Consumers are advised to check lot numbers and discontinue use of affected products.

Gold Star Distribution Recalls FDA Products Due to Contamination

Gold Star Distribution, Inc. is recalling all FDA-regulated products held at its facility due to rodent, avian, and insect contamination and insanitary conditions. The FDA determined the facility operated under insanitary conditions, posing a significant risk of product contamination and potential illness from microorganisms like Salmonella.

Navafresh Recalls Rheumacare Capsules Due to Elevated Lead Levels

Handelnine Global Limited d/b/a Navafresh is voluntarily recalling Rheumacare Capsules due to elevated lead levels found by the FDA. The recall impacts consumers nationwide and is being conducted with the FDA's knowledge.

Modern Warrior Recalls Dietary Supplement Due to Undeclared Ingredients

Modern Warrior is voluntarily recalling its 'Modern Warrior Ready' dietary supplement due to the presence of undeclared tianeptine, 1,4-DMAA, and aniracetam. The FDA is highlighting the serious health risks associated with these ingredients, including potential life-threatening cardiovascular events and suicidal ideation.

Toyota SUV Recall - Faulty Second-Row Seat Recliners

Transport Canada has issued a recall for certain Toyota SUVs due to improperly manufactured second-row seat recliners that may not lock in position. Toyota recommends not using the second-row seats for passengers until repairs are completed. Owners will be notified to replace a part in the seat recliner assembly.

Katilo Classic Roomy Recalled for Salmonella Contamination

The Canadian Food Inspection Agency (CFIA) has issued a food recall warning for Katilo brand Classic Roomy due to potential Salmonella contamination. Consumers are advised not to consume, use, sell, serve, or distribute the affected product.

IntelliVue MX Patient Monitor System EC10 Recall

Health Canada has issued a Type II recall for the Philips IntelliVue MX Patient Monitor System-IntelliBridge Module EC10. The recall is due to a potential safety issue where the system may fail to alarm for 'No Device Data' INOP, affecting patient safety. Healthcare providers are advised to contact the manufacturer for additional information.

Glacial Gold Fuzzy Mango Recalled Due to Packaging and Labelling Issues

Nextleaf Labs Ltd. is recalling Glacial Gold – Anytime 1:1 Fuzzy Mango cannabis extract due to incorrect cannabinoid values on the label and packaging issues. Approximately 1998 units were sold in Alberta, British Columbia, and Saskatchewan. Consumers are advised to check if their product is affected and return it to the store.

Venlafaxine XR Recall

Health Canada has issued a Type II recall for VENLAFAXINE XR 75mg capsules due to dissolution testing being out of specification. Retailers are instructed to remove the affected product from shelves. Consumers should consult a healthcare provider before discontinuing use.

Choco Lake Diamond Twist Chocolate Recalled Due to Aflatoxin Contamination

The Canadian Food Inspection Agency has issued a recall for Choco Lake Diamond Twist brand Milk Chocolate with Kunafa Pistachio Paste Flavor due to aflatoxin contamination. The recall affects products distributed in Ontario, with specific lot codes and expiry dates identified.

Worthy Crumb Pastry Co. Scones Recalled Due to Mould

The Canadian Food Inspection Agency has issued a recall for The Worthy Crumb Pastry Co. brand Cheddar and Chive Artisan Scones due to mould contamination. The product was distributed nationally, and consumers are advised not to use or distribute the affected product.

HHS OIG: Over $15 Million in Improper Medicare Payments for Non-Emergency Services

The HHS Office of Inspector General (OIG) reported that Medicare improperly paid physicians $922,524 and potentially $14.2 million to hospitals for services billed with emergency department procedure codes but rendered at non-emergency sites. The OIG recommends recovery of improper payments and improved claims processing controls.

Vicks Sinus Steam Inhaler Recall

Health Canada has issued a recall for the Vicks Sinus Steam Inhaler (VIH200CV1) because it was distributed without the required Medical Device License. Consumers are advised to retain the product and contact Kaz USA Inc. for further instructions.

Chikungunya Vaccine IXCHIQ: Risks for Frail Seniors 65+

Health Canada has issued updated safety information regarding the chikungunya vaccine IXCHIQ. Medically frail individuals aged 65 and older may be at increased risk of serious adverse reactions. Healthcare professionals are advised to carefully assess risks and benefits for this demographic.

Ketorolac Recalled Due to Weight Out of Specification

Health Canada has issued a Type II recall for Ketorolac (DIN 02245821) manufactured by AA Pharma Inc. due to weight being out of specification in affected lots VE3252 and VE3251. Retailers are instructed on the recall process and consumers are advised to consult healthcare providers.

New York Private Well PFAS Testing and Rebate Pilot Program

New York State has launched a pilot program offering free PFAS testing and rebates for water treatment systems or connection to public water for private well owners in six counties. The program aims to address PFAS contamination in drinking water and is funded with $1.5 million per county.

FDA Guidance: Flavored ENDS Premarket Applications

The FDA has issued guidance to assist with premarket tobacco product applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS). This guidance, intended to improve submission and review efficiency, focuses on considerations related to youth risk. The document is non-binding and aims to inform potential future rulemaking.

FDA Draft Q&As on Biosimilar Development and BPCI Act

The FDA has issued a draft guidance document providing updated answers to common questions regarding biosimilar development and the Biologics Price Competition and Innovation Act (BPCI Act). This revision replaces a previous draft and focuses on specific Q&As related to the abbreviated licensure pathway for biological products.

FDA Q&A on Biosimilar Development and BPCI Act

The FDA has reissued its final guidance on biosimilar development and the BPCI Act, solely to withdraw three specific Q&As (I.8, I.10, and I.19). The agency is continuing to evaluate other Q&As for potential updates.

Transport Canada Truck Recall - Electrical Issue

Transport Canada has issued a recall for certain Western Star and Freightliner trucks due to an improperly installed tarp system relay that poses a fire risk. Owners will be notified by mail to inspect and potentially reinstall the relay.

Ford Escape, Bronco Sport Recall - Fuel Injector Crack

Transport Canada has issued a recall for certain 2020-2022 Ford Escape and Bronco Sport vehicles due to a potential fuel injector crack, which could lead to a fuel leak and fire risk. Ford will notify owners to update software and install a drain tube, with an extended warranty for injector replacement.

Ford SUV Recall - Fuel Injector Leak Risk

Transport Canada has issued recall 2024160 for certain 2022-2023 Ford Escape and Bronco Sport models due to a risk of fuel leaks from cracked fuel injectors, which could lead to engine compartment fires. Ford will notify owners to update software and install a drain tube, with an extended warranty for injector replacement.

Colorado Public Health Officials Identify Additional Measles Cases

Colorado public health officials have identified four additional measles cases in Adams and Weld Counties, bringing the total number of cases tied to Broomfield High School and Broomfield Heights Middle School to a higher number. The notice provides updated information on known exposure locations and dates for the public.

Vimal Patel Pharmacist Discipline and Public Complaint

The Florida Department of Health has a public complaint and disciplinary action on file for pharmacist Vimal G. Patel (License PS37396). The details of the disciplinary action are available via the provided link.

Pharmacist Mary Stieber License Disciplinary Action

The Florida Department of Health has taken disciplinary action against Pharmacist Mary Stieber, resulting in the relinquishment of her license. The license status is now listed as 'Disc Relinquish'. Further details are available through the department's online portal.

Pharmacy Practitioner Discipline on File

The Florida Department of Health has updated the disciplinary record for Holiday CVS, LLC, and CVS Pharmacy #00319. The license verification indicates that there is discipline on file and a public complaint against the pharmacy.

Serenity House Detox Palm Beach LLC Pharmacy License Revoked

The Florida Department of Health has revoked the pharmacy license for Serenity House Detox Palm Beach LLC. The license, PH29291, was originally issued on August 5, 2015, and had an expiration date of February 28, 2025. This action indicates a significant disciplinary measure against the facility.

Florida Pharmacy License Revoked

The Florida Department of Health has revoked the pharmacy license of Golden Glades Treatment Center. The license status was modified, and discipline is on file, indicating a significant regulatory action against the facility.

Pharmacy License Probation for Harmony Discount Pharmacy

The Florida Department of Health has placed Harmony Discount Pharmacy LLC's pharmacy license (PH33486) on probation. This disciplinary action is effective April 25, 2024, and indicates a public complaint and disciplinary action on file.

Pharmacy Technician License Revoked

The Florida Department of Health has revoked the pharmacy technician license of Alexis Amanda Correa (RPT109247). The license status is listed as Revoked, with an expiration date of 12/31/2024. Discipline and a public complaint are on file.

Pharmacy Technician License Revoked

The Florida Department of Health has revoked the pharmacy technician license of Maurissa Latrae Wheeler (License RPT72593). This action indicates a significant disciplinary measure taken against the individual's professional license.

Dalton Erickson Pharmacy Technician Discipline Florida

The Florida Department of Health has recorded disciplinary action against pharmacy technician Dalton Erickson. The license status is listed as 'Disc Relinquish', indicating a voluntary surrender or relinquishment of the license, with a public complaint also on file.

Pharmacy Technician License Revoked

The Florida Department of Health has revoked the pharmacy technician license of Stacy Johnson Lewis (License Number RPT106728). The revocation is effective immediately, and the license expiration date was December 31, 2024. Further details regarding disciplinary actions are available through the Department.

Jayda Krueger Pharmacy Technician License Suspended

The Florida Department of Health has suspended the pharmacy technician license of Jayda Krueger (License Number RPT118858). The license is set to expire on December 31, 2026, and the suspension is effective immediately. Discipline and public complaint information are on file.

Pharmacy License Verification with Discipline

This document provides a verification of a pharmacy license, PH2470, for PELOT'S PHARMACY in Florida. The record indicates that there is disciplinary action and a public complaint on file for this license.

Pharmacist Alyssa Sanders Discipline on File

The Florida Department of Health has placed disciplinary action on file for Pharmacist Alyssa Marie Sanders (License Number PS67590). This action indicates a public complaint has been filed and requires review of the Discipline/Admin Action tab for details.

Honda and Acura SUV Recall - Instrument Cluster Display Issue

Transport Canada has issued a recall for 2024 Honda Prologue and Acura ZDX SUVs due to a software issue that can cause the instrument cluster and infotainment display to go blank while driving. This poses a safety risk by preventing drivers from seeing critical information and the rearview camera.

International Motors Bus Recall - Brake Line Issue

Transport Canada has issued a recall for certain 2025-2026 IC BUS CE COMMERCIAL BUS models manufactured by International Motors due to a potential brake line issue. The recall addresses the risk of reduced braking performance, increasing the risk of a crash.

BMW Motorcycle Recall - Turn Signals May Not Work

Transport Canada has issued a recall for BMW motorcycles due to a potential defect in the left combination switch, which may prevent turn signals from functioning. The issue poses a safety risk, as non-functional turn signals could increase the risk of a crash. Affected motorcycles have not yet been delivered to customers.

International Motors School Bus Brake Lines Recalled

Transport Canada has issued a recall for International Motors school buses due to a potential issue with brake lines not being secured correctly. This could lead to brake fluid leaks and reduced braking capability, increasing the risk of a crash. Owners will be notified to have the brake lines inspected and replaced.

Draft Guidance: Responding to FDA Form 483 Observations for Drug Manufacturers

The FDA has issued draft guidance for drug manufacturers on how to respond to observations noted on FDA Form 483 following CGMP inspections. This guidance is intended to assist domestic and foreign manufacturers in assessing conformity with CGMP requirements.